[Form 4] Confluent, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Confluent, Inc. (CFLT) Form 4: The reporting person, Chief Accounting Officer Phan Kong, sold 2,664 shares of Class A common stock on 08/20/2025 to cover tax obligations from RSU vesting. Sale prices ranged from $17.01 to $17.08, and the reporting person owned 237,078 shares following the transaction. The Form 4 was signed by an attorney-in-fact on 08/22/2025.

Insights

Financial Analyst

TL;DR: Insider sold a small number of shares to satisfy tax liabilities; ownership remains substantial and this is routine.

The disclosed sale of 2,664 shares at prices between $17.01 and $17.08 appears to be a tax-related disposition tied to RSU vesting rather than an opportunistic market sale. Post-transaction beneficial ownership is 237,078 shares, indicating continued significant insider stake. For investors, this is informational rather than a material signal about company fundamentals.

Corporate Governance Expert

TL;DR: Transaction aligns with common practice of selling shares to cover tax on equity compensation; no governance concern disclosed.

The filing identifies the reporting person as the Chief Accounting Officer and notes the sale was to cover taxes from vested restricted stock units. The Form 4 was properly executed by an attorney-in-fact. There are no disclosures of rule 10b5-1 plans or other arrangements in this filing, and the nature of the sale is consistent with routine insider compliance with tax obligations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Phan Kong

(Last) (First) (Middle)

C/O CONFLUENT, INC.

899 W. EVELYN AVENUE

(Street)

MOUNTAIN VIEW CA 94041

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Confluent, Inc. [ CFLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/20/2025		S		2,664(1)	D	$17.01(2)	237,078	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.

2. The shares were sold at prices ranging from $17.01 to $17.08. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Weilyn Wood, Attorney-in-Fact	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Confluent (CFLT) insider Phan Kong report on Form 4?

The Chief Accounting Officer sold 2,664 shares on 08/20/2025 to cover tax obligations from vested RSUs.

At what price were the CFLT shares sold according to the Form 4?

The shares were sold at prices ranging from $17.01 to $17.08; exact per-price breakdown is available upon request.

How many CFLT shares did the reporting person own after the transaction?

The reporting person beneficially owned 237,078 shares following the reported sale.

When was the Form 4 signed for the CFLT insider transaction?

The Form 4 was signed by an attorney-in-fact on 08/22/2025.

Was the sale part of a 10b5-1 trading plan according to the filing?

The filing does not indicate that the transaction was made pursuant to a 10b5-1 trading plan.